스카이테라퓨틱스

KRW 13.0B Series C

Announced: Jul 13, 2026
Sector: Biotechnology
Investors: 2

Summary

스카이테라퓨틱스 raised 130억원 in a Series C round. The company works on innovative drug and cosmetics raw materials. 스카이테라퓨틱스 is a developer of novel drug and cosmetics raw materials.

Investors

본엔젤스벤처파트너스, 쏠리드엑스